deaths (OS)

mNSCLC - L2 - all population metastatic/advanced NSCLC (mNSCLC) - 2nd line (L2) mNSCLC - L2 - all population

versus docetaxel
atezolizumab alone vs. docetaxel 2 0.79
avelumab alone vs. docetaxel 1 0.90
nivolumab alone vs. docetaxel 1 0.68
Tislelizumab vs. docetaxel 1